Home >> Life Sciences >> Healthcare

Huntington Disease - Pipeline Review, H1 2017

Published: Jun-2017 | Format: PDF | Global Markets Direct | Number of pages: 299 | Code: MRS - 139815

Huntington Disease - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Huntington Disease - Pipeline Review, H1 2017, provides an overview of the Huntington Disease (Central Nervous System) pipeline landscape.

Huntington's disease (HD) is an inherited disease that causes certain nerve cells in the brain to waste away. HD is a familial disease that is passed on from parent to child through a mutation in their genes. Early symptoms of HD include uncontrolled movements, clumsiness, and balance problems. Later, HD can take away the ability to walk, talk, and swallow.  

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Huntington Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Huntington Disease (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Huntington Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Huntington Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 10, 6, 50 and 18 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 22 and 5 molecules, respectively.

Huntington Disease (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Huntington Disease (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Huntington Disease (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Huntington Disease (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Huntington Disease (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 
- The pipeline guide reviews latest news related to pipeline therapeutics for Huntington Disease (Central Nervous System)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Huntington Disease (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Huntington Disease (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2
Introduction 6
Huntington Disease - Overview 7
Huntington Disease - Therapeutics Development 8
Huntington Disease - Therapeutics Assessment 24
Huntington Disease - Companies Involved in Therapeutics Development 36
Huntington Disease - Drug Profiles 64
Huntington Disease - Dormant Projects 270
Huntington Disease - Discontinued Products 275
Huntington Disease - Product Development Milestones 276
Appendix 287

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Related Reports

Asia-Pacific Veno-Arterial ECMO System Market by Manufacturers, Regions, Type and Application, Forecast to 2022

Jan-2018 | Global Info Research | Pages : 119 | Code : MRS-201182 | 4480

This report studies the Veno-Arterial ECMO System market. Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. Veno-Arterial ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since Veno-Arterial ECMO is a complicated and high-risk therapy, adequate training in its performance and cr Read more

Asia-Pacific Intrauterine Devices Market by Manufacturers, Regions, Type and Application, Forecast to 2022

Jan-2018 | Global Info Research | Pages : 123 | Code : MRS-201181 | 4480

"Intrauterine devices (IUDs) are contraceptive medical implants used to prevent pregnancies for a long period of time. They are also known as long-acting reversible contraceptive devices. An IUD is a T-shaped device, made of flexible plastic, with a copper wire wrapped around its stem, and is considered a safe and reliable method of sterilization for women. It is inserted into the uterus, and its primary aim is to prevent the fertilization of the egg by causing changes." Scope of the Re Read more

Asia-Pacific Clinical Immunoanalyzer Market by Manufacturers, Regions, Type and Application, Forecast to 2022

Jan-2018 | Global Info Research | Pages : 121 | Code : MRS-201180 | 4480

Clinical Immunoanalyzer detect and quantify specific analytes in blood or in samples of body fluids by utilizing immunoassay methodologies such as immunoprecipitation, particle immunoassays, immunonephelometry, radioimmunoassay, enzyme immunoassay, fluorescent immunoassay, and chemiluminescent immunoassays. Scope of the Report: This report focuses on the Clinical Immunoanalyzer in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This Read more

EMEA (Europe, Middle East and Africa) Probiotics Market 2017 Forecast to 2022

Jan-2018 | Global Info Research | Pages : 117 | Code : MRS-201179 | 4480

Probiotics are live micro-organisms which, when administrated in adequate amounts, confer a health benefit on the host. While the traditional delivery vehicle for probiotics was fresh dairy products, they are now found in many varieties of food, beverages, dietary supplements and healthcare products. Scope of the Report: This report focuses on the Probiotics in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, typ Read more

EMEA (Europe, Middle East and Africa) Dental Drug Market 2017 Forecast to 2022

Jan-2018 | Global Info Research | Pages : 121 | Code : MRS-201178 | 4480

There are a number of different drugs that dentist may prescribe, depending on patient’s condition. Some medications are prescribed to fight certain oral diseases, to prevent or treat infections, or to control pain and relieve anxiety. The dose of the drugs and instructions on how to take them will differ from patient to patient, depending on what the drug is being used for, patient's age, weight, and other considerations. Scope of the Report: This report focuses on the Dental Drug in Read more

EMEA (Europe, Middle East and Africa) Antibody Market 2017 Forecast to 2022

Jan-2018 | Global Info Research | Pages : 115 | Code : MRS-201177 | 4480

"In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. IVD antibodies are widely used for immunology methods such as immunonephelometry and sandwich ELISA. This report only researched the antibody are for in vitro diagnostic (IVD) use." Scope of the Report: This report focuses on the Antibody in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application. Read more

EMEA (Europe, Middle East and Africa) Vitamin K2 Market 2017 Forecast to 2022

Jan-2018 | Global Info Research | Pages : 121 | Code : MRS-201176 | 4480

Vitamin K2 is the term for a group of compounds called ‘menaquinones,’ which can be found mainly in dairy products. All K vitamins are similar in structure, but differ in the length of the “side chain”. The longer the side chain, the better effect and efficiency. Scope of the Report: This report focuses on the Vitamin K2 in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application. Market Segment b Read more

EMEA (Europe, Middle East and Africa) Veterinary Diagnostic Imaging Market 2017 Forecast to 2022

Jan-2018 | Global Info Research | Pages : 122 | Code : MRS-201175 | 4480

"Veterinary diagnostic imaging equipment is primarily used for imaging the animal body with the help of various imaging technologies. Diagnostic imaging is the noninvasive method of making medical images of the body to diagnose disease." Scope of the Report: This report focuses on the Veterinary Diagnostic Imaging in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manu Read more

EMEA (Europe, Middle East and Africa) PSA Test Market 2017 Forecast to 2022

Jan-2018 | Global Info Research | Pages : 122 | Code : MRS-201174 | 4480

"Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene. The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood." Scope of the Report: This report focuses on the PSA Test in EMEA market, covering Europe, Middle East and Africa, This repo Read more

EMEA (Europe, Middle East and Africa) Intravenous Immunoglobulin (IVIg) Market 2017 Forecast to 2022

Jan-2018 | Global Info Research | Pages : 123 | Code : MRS-201173 | 4480

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin. Scope of the Report: This report focuses on the Intravenous Immunoglobulin (IVIg) in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, Read more

Single User | $(USD)2000 View Pricing